<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Linalool is a sedative, an antidepressant, and an anticancer, antifungal, and pesticidal EO [
 <xref rid="B177-ijms-19-01966" ref-type="bibr" class="xref">177</xref>,
 <xref rid="B178-ijms-19-01966" ref-type="bibr" class="xref">178</xref>,
 <xref rid="B179-ijms-19-01966" ref-type="bibr" class="xref">179</xref>,
 <xref rid="B180-ijms-19-01966" ref-type="bibr" class="xref">180</xref>]. It is neither toxic nor irritable to skin. It presents an extremely low risk of skin sensitization [
 <xref rid="B8-ijms-19-01966" ref-type="bibr" class="xref">8</xref>]. No positive skin reactions were observed when testing the 97% pure linalool at 20%, or to oxidized linalool tested at 1% in dermatitis and eczema patients [
 <xref rid="B175-ijms-19-01966" ref-type="bibr" class="xref">175</xref>,
 <xref rid="B181-ijms-19-01966" ref-type="bibr" class="xref">181</xref>]. Linalool does not cause photo-irritation or photo-allergy because it does not absorb UV light in the range of 290–400 nm [
 <xref rid="B182-ijms-19-01966" ref-type="bibr" class="xref">182</xref>]. No fetal toxicity was observed [
 <xref rid="B8-ijms-19-01966" ref-type="bibr" class="xref">8</xref>]. No carcinogenic, mutagenic, or genotoxic activities were found [
 <xref rid="B8-ijms-19-01966" ref-type="bibr" class="xref">8</xref>]. The acute dermal LD
 <sub class="sub">50</sub> was 5.61 g/kg in rabbits, while the acute oral LD
 <sub class="sub">50</sub> was 2.79 g/kg in rats [
 <xref rid="B183-ijms-19-01966" ref-type="bibr" class="xref">183</xref>] and 2.2–3.92 g/kg in mice [
 <xref rid="B184-ijms-19-01966" ref-type="bibr" class="xref">184</xref>]. High doses of linalool cause ataxia and narcosis [
 <xref rid="B185-ijms-19-01966" ref-type="bibr" class="xref">185</xref>].
</p>
